As of September 29, 2026, Compugen's top three insider holders are David Silberman (Chief Financial Officer, 55.00K shares), Zurit Levine (Svp, Business Development, 47.38K shares), Russo Sharon Kredo (Svp, Research Discovery, 37.50K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David Silberman | Chief Financial Officer | 55,000 | 0 | 55,000 | 19.4% | 30 Jul, 2026 |
| 2 | Zurit Levine | Svp, Business Development | 47,375 | 0 | 47,375 | 16.8% | 30 Jul, 2026 |
| 3 | Russo Sharon Kredo | Svp, Research Discovery | 37,500 | 0 | 37,500 | 13.3% | 30 Jul, 2026 |
| 4 | Michelle Mahler | Chief Medical Officer | 36,625 | 0 | 36,625 | 13.0% | 30 Jul, 2026 |
| 5 | Savitzky Kinneret Livnat | Director | 20,850 | 0 | 20,850 | 7.4% | 30 Jul, 2026 |
| 6 | Sanford S Zweifach | Director | 20,180 | 0 | 20,180 | 7.1% | 30 Jul, 2026 |
| 7 | Gilead Halevy | Director | 18,907 | 0 | 18,907 | 6.7% | 30 Jul, 2026 |
| 8 | Eran Perry | Director | 17,500 | 0 | 17,500 | 6.2% | 30 Jul, 2026 |
| 9 | Mathias Hukkelhoven | Director | 17,500 | 0 | 17,500 | 6.2% | 30 Jul, 2026 |
| 10 | Eran Ophir | President And Ceo | 11,375 | 0 | 11,375 | 4.0% | 27 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 29 Jul, 2026 | Eran Perry | Director | Acquired A | 7,500 | $0.00 | $0 | 17,500 | Direct |
| 29 Jul, 2026 | Mathias Hukkelhoven | Director | Acquired A | 7,500 | $0.00 | $0 | 17,500 | Direct |
| 29 Jul, 2026 | Russo Sharon Kredo | Svp, Research Discovery | Acquired A | 18,000 | $0.00 | $0 | 37,500 | Direct |
| 29 Jul, 2026 | Savitzky Kinneret Livnat | Director | Acquired A | 7,500 | $0.00 | $0 | 20,850 | Direct |
| 29 Jul, 2026 | Eran Ophir | President And Ceo | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |
| 29 Jul, 2026 | Michelle Mahler | Chief Medical Officer | Acquired A | 13,500 | $0.00 | $0 | 36,625 | Direct |
| 29 Jul, 2026 | Pierre Ferre | Chief Operating Officer | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 29 Jul, 2026 | Zurit Levine | Svp, Business Development | Acquired A | 18,000 | $0.00 | $0 | 47,375 | Direct |
| 29 Jul, 2026 | Gilead Halevy | Director | Acquired A | 7,500 | $0.00 | $0 | 18,907 | Direct |
| 29 Jul, 2026 | David Silberman | Chief Financial Officer | Acquired A | 19,500 | $0.00 | $0 | 55,000 | Direct |
| 29 Jul, 2026 | Anat Cohen-Dayag | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 29 Jul, 2026 | Sanford S Zweifach | Director | Acquired A | 7,500 | $0.00 | $0 | 20,180 | Direct |
| 29 Jul, 2026 | Sanford S Zweifach | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Russo Sharon Kredo | Svp, Research Discovery | Acquired A | 24,000 | $0.00 | $0 | 24,000 | Direct |
| 29 Jul, 2026 | David Silberman | Chief Financial Officer | Acquired A | 26,000 | $0.00 | $0 | 26,000 | Direct |
| 29 Jul, 2026 | Zurit Levine | Svp, Business Development | Acquired A | 24,000 | $0.00 | $0 | 24,000 | Direct |
| 29 Jul, 2026 | Eran Perry | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Gilead Halevy | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Mathias Hukkelhoven | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 29 Jul, 2026 | Michelle Mahler | Chief Medical Officer | Acquired A | 18,000 | $0.00 | $0 | 18,000 | Direct |